MesotheliomaDoc
:: Mesothelioma  :: Mesothelioma & Asbestos  :: Malignant Mesothelioma  :: Clinical Trials  :: Statistics  :: Disclaimer 
Google
Web Mesotheliomadoc.com


 What is Mesothelioma
 Mesothelioma and Asbestos
 Malignant Mesothelioma and Treatment
  Stages of Malignant Mesothelioma
  Recurrent Malignant Mesothelioma
  Treatment option overview
  Treatment options for Malignant Mesothelioma
 Clinical Trials
 Statistics



Provided by MedicineNet

Malignant Mesothelioma and Treatment



Treatment Options for Malignant Mesothelioma

Localized Malignant Mesothelioma (Stage I)
Advanced Malignant Mesothelioma (Stage II, Stage III, and Stage IV)
Recurrent Malignant Mesothelioma



Localized Malignant Mesothelioma (Stage I)

If the malignant mesothelioma is in one part of the chest lining, treatment will probably be surgery to remove the part of the chest lining with cancer and some of the tissue around it.

If localized malignant mesothelioma is found in more than one place in the chest, treatment may be one of the following:

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.

Advanced Malignant Mesothelioma (Stage II, Stage III, and Stage IV)

Treatment of advanced malignant mesothelioma may include the following:

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.

Recurrent Malignant Mesothelioma

Treatment of recurrent malignant mesothelioma may include the following:

This summary section refers to specific treatments under study in clinical trials, but it may not mention every new treatment being studied. Information about ongoing clinical trials is available from the NCI Web site.

Back to Top

< Previous Section  


         Copyright 2005.Mesotheliomadoc.com All rights reserved Content's source: www.cancer.gov